Gsk (GSK) Cash from Investing Activities Growth (5y) (2014 - 2026)
Powered by 
Analysis
Gsk (GSK) Cash from Investing Activities Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 618.86 Bn | 602.88 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 361.40 Bn | 361.40 Bn | - |
| 3 | General Electric | 329.38 Bn | 320.03 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.73 Bn | 248.44 Bn | 12.86 Bn |
| 5 | Citigroup | 228.07 Bn | -2,074.24 Bn | 24.75 Bn |
| 6 | Bhp | 216.09 Bn | 197.55 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 197.36 Bn | 195.32 Bn | - |
| 9 | Unilever | 139.15 Bn | 132.12 Bn | - |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.37% |
| Mar 31, 2026 | -97.25% |
| Dec 31, 2025 | 24.42% |
| Sep 30, 2025 | -13.69% |
| Mar 31, 2025 | -80.91% |
| Dec 31, 2024 | 21.36% |
| Sep 30, 2024 | 37.84% |
| Mar 31, 2024 | 48.36% |
| Dec 31, 2023 | 48.39% |
| Mar 31, 2023 | 0.79% |
| Dec 31, 2022 | -41.43% |
| Mar 31, 2022 | -81.24% |
| Dec 31, 2021 | -15.70% |
| Mar 31, 2021 | 41.38% |
| Dec 31, 2020 | -20.51% |
| Mar 31, 2020 | -14.95% |
| Dec 31, 2019 | -49.97% |
| Sep 30, 2019 | -9.84% |
| Mar 31, 2019 | -56.24% |
| Dec 31, 2018 | 8.35% |